GlassScriptPhysician profile
Bridgette A Cooke
NPI 1023504735
$9,987.45
in general payments reported to CMS, 2019-2025
61 companies · $1,798 in 2025
The $1,798 reported for 2025 was more than what 91% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,865 · 2022: $1,717 · 2023: $2,081 · 2024: $2,526 · 2025: $1,798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,121 · Education: $262 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $21.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,121.07 |
| Education | $262.49 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,464.60 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $1,153.40 | 2022-2025 | Austedo Xr, Ajovy, Austedo Xr |
| Ucb, INC. | $643.72 | 2021-2025 | Briviact, Fintepla, Rystiggo |
| Celgene Corporation | $482.35 | 2021-2025 | Zeposia |
| Impel Pharmaceuticals INC. | $316.71 | 2022-2023 | Trudhesa |
| Sunovion Pharmaceuticals INC. | $316.55 | 2021-2022 | |
| Amgen INC. | $315.01 | 2021-2025 | Aimovig, Uplizna |
| Novartis Pharmaceuticals Corporation | $302.07 | 2022-2025 | |
| Neurocrine Biosciences, INC. | $292.01 | 2021-2024 | Ingrezza, Ongentys |
| Biogen, INC. | $285.16 | 2021-2025 | Vumerity |
| Acadia Pharmaceuticals INC | $279.05 | 2021-2025 | Nuplazid |
| Jazz Pharmaceuticals INC. | $272.51 | 2022-2025 | |
| Sk Life Science, INC. | $253.10 | 2021-2025 | |
| Tg Therapeutics, INC. | $224.82 | 2023-2025 | |
| Pfizer INC. | $221.40 | 2023-2025 |
Show all 61 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceuticals, INC. | $221.22 | 2021 | |
| Emd Serono, INC. | $218.76 | 2021-2025 | |
| Lilly USA, LLC | $202.74 | 2021-2025 | Amyvid, Emgality, Kisunla |
| Neurelis, INC. | $162.12 | 2021-2025 | Valtoco |
| Lundbeck LLC | $146.21 | 2022-2024 | Vyepti, Rexulti |
| Argenx US, INC. | $133.00 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Merz Pharmaceuticals, LLC | $132.76 | 2021-2025 | Xeomin, Inbrija, Ampyra |
| Acorda Therapeutics, INC | $124.62 | 2021-2024 | Ampyra, Inbrija |
| Averitas Pharma INC. | $119.21 | 2023-2024 | Qutenza |
| Impel Pharmaceuticals LLC | $113.31 | 2024-2025 | Trudhesa |
| Greenwich Biosciences, INC. | $110.10 | 2021 | |
| Eisai INC. | $106.67 | 2021-2024 | |
| Mdd US Operations, LLC | $102.53 | 2024-2025 | Apokyn, Gocovri |
| Takeda Pharmaceuticals U.S.A., INC. | $101.87 | 2023-2025 | Hyqvia, Gammagard, Trintellix |
| Avadel Cns Pharmaceuticals, LLC | $84.37 | 2023-2025 | Lumryz |
| Almatica Pharma LLC | $79.85 | 2021 | |
| Grt US Holding, INC. | $61.92 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $61.72 | 2021-2023 | |
| Amneal Pharmaceuticals LLC | $61.51 | 2021-2025 | Rytary, Crexont |
| Genzyme Corporation | $60.40 | 2021-2023 | |
| Genentech USA, INC. | $59.00 | 2022-2025 | Ocrevus Zunovo, Ocrevus |
| Ge Healthcare | $54.24 | 2022-2023 | |
| Avion Pharmaceuticals | $48.72 | 2022-2023 | Dhivy |
| Kyowa Kirin, INC. | $46.77 | 2021-2023 | Nourianz |
| Janssen Pharmaceuticals, INC | $45.18 | 2021-2022 | |
| Livanova USA, INC. | $38.69 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Alexion Pharmaceuticals, INC. | $38.23 | 2021-2023 | Ultomiris |
| Sumitomo Pharma America, INC. | $36.09 | 2023 | Aptiom |
| Avanir Pharmaceuticals, INC. | $35.72 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $32.64 | 2022 | |
| Medtronic, INC. | $30.75 | 2025 | Percept PC Brainsense |
| Aucta Pharmaceuticals, INC. | $27.92 | 2025 | Motpoly Xr |
| Axsome Therapeutics, INC. | $27.49 | 2025 | Sunosi |
| Noctrix Health, INC. | $24.89 | 2024 | Nidra |
| Banner Life Sciences, LLC | $24.50 | 2022 | |
| Tersera Therapeutics LLC | $20.57 | 2025 | Quzyttir |
| Csl Behring | $20.17 | 2022 | |
| Tanabe Pharma America, INC. | $19.09 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $18.88 | 2023 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $17.86 | 2024 | Wainua |
| Collegium Pharmaceutical, INC. | $17.84 | 2022 | |
| Idorsia Pharmaceuticals US INC | $17.58 | 2023 | Quviviq |
| Azurity Pharmaceuticals, INC. | $15.39 | 2024 | Horizant |
| Scilex Pharmaceuticals INC. | $15.05 | 2023 | Ztlido |
| Inspire Medical Systems, INC. | $14.62 | 2024 | Inspire |
| Mallinckrodt Hospital Products INC. | $12.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bridgette Cooke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.